Search Results

Displaying Results 6076-6100 of 12267 "'L'"

Dec 17, 2025, 09:00 ET Kinetic Technologies Announces Elevated Tablet Panel Power IC with 12-bit Gamma 2.2 Dimming for Next Generation High-Resolution and High-Refresh Rate Displays

display design a solution that integrates what previously were three ICs into one small chip. It is available in a RoHS and green compliant WQFN55-32L (5mm x 5mm, 32 Lead) tiny package. Powering 80 LEDs with its protection-rich, robust built-in features including inductor current limit protection, output

More news about: Kinetic Technologies


Dec 17, 2025, 08:58 ET Samson Sky CEO Receives Global Innovator Award at Congressional Ceremony on Capitol Hill

Subcommittee. Following this, Bousfield was presented with a U.S. Congressional Medallion along with a U.S. Congressional Proclamation by U.S. Rep. Jonathan L. Jackson (IL), Member of the House Foreign Affairs Committee and Member of the House Agriculture Committee.These awards recognize Bousfield and

More news about: Samson Sky


Dec 17, 2025, 08:48 ET ANTARES VISION GROUP PRÉSENTE LA NOUVELLE ÈRE DE LA CHAÎNE DE DISTRIBUTION PHARMACEUTIQUE

pourront en apprendre davantage sur les architectures, les cas d'utilisation et les meilleures pratiques, le Groupe présentera sa plateforme full stack L1-L4. Celle-ci intègre la sérialisation, l'agrégation, la traçabilité de bout en bout et l'inspection automatisée des emballages primaires et secondaires.

More news about: Antares Vision Group


Dec 17, 2025, 08:31 ET Connor, Clark & Lunn Infrastructure and Alpenglow Rail announce closing of $280 million private placement financing

including railcar storage, switching, transloading and railcar cleaning, among others.Ryan Lapointe, Managing Director at CC&L Infrastructure, commented: "CC&L Infrastructure is pleased to complete this successful financing, which underscores the strength of our partnership with Alpenglow

More news about: Connor, Clark & Lunn Infrastructure


Dec 17, 2025, 08:30 ET Bench International Announces Appointment of Jim Lang to the Board of Directors of Halozyme Therapeutics

Their thorough approach and commitment to excellence resulted in identifying Jim Lang — an outstanding match for the high standards we set," said Matthew L. Posard, Chairman of Halozyme's Nominating and Governance Committee and a member of the Board of Directors.The appointment reflects Halozyme's

More news about: Bench International


Dec 17, 2025, 08:01 ET Nona Biosciences and Valink Therapeutics Form Strategic Alliance to Accelerate Novel Biologics Discovery

research.Nona's proprietary antibody platform Harbour Mice® generates fully human monoclonal antibodies in classical two light and two heavy chain (H2L2) format, and heavy chain-only (HCAb) format. The HCAb Harbour Mice® is the world's first fully human HCAb transgenic mouse with clinical

More news about: Nona Biosciences


Dec 17, 2025, 08:00 ET Guavy Launches iOS App: AI-Powered Market Sentiment and Signals for Cryptocurrency Traders

glance.Trade Simulations – Mock trade simulations that let users backtest Guavy's signals by tracking hypothetical entries, exits, and P&L, and toggling between conservative and aggressive risk profiles.Sentiment-Driven News Feed – A live, sentiment-aware news stream that

More news about: Guavy Inc.


Dec 17, 2025, 08:00 ET Guavy Launches iOS App: AI-Powered Market Sentiment and Signals for Cryptocurrency Traders

glance.Trade Simulations – Mock trade simulations that let users backtest Guavy's signals by tracking hypothetical entries, exits, and P&L, and toggling between conservative and aggressive risk profiles.Sentiment-Driven News Feed – A live, sentiment-aware news stream that

More news about: Guavy Inc.


Dec 17, 2025, 06:45 ET PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

countries around the world. PADCEV is also approved as a single agent for the treatment of adult patients with la/mUC who have previously received a PD-1/PD-L1 inhibitor and platinum-containing chemotherapy or are ineligible for cisplatin-containing chemotherapy and have previously received one or more prior

More news about: Astellas Pharma Inc.


Dec 17, 2025, 06:26 ET ATTACK SHARK presenta V8, un ratón inalámbrico ligero para juegos de última generación

el estado de la batería, ofreciendo una experiencia inalámbrica fiable e ininterrumpida para el juego competitivo.Equipado con el chip Nordic 54L15, con una frecuencia de núcleo el doble que la de los chips 52840, el V8 ofrece tasas de sondeo duales de 8K para una actualización de entrada ultrarrápida.

More news about: ATTACK SHARK


Dec 17, 2025, 06:24 ET ATTACK SHARK stellt die V8 vor: Eine leichte kabellose Gaming-Maus der nächsten Generation, entwickelt für Wettbewerbsvorteile

und Akkustand und sorgt so für ein zuverlässiges, unterbrechungsfreies Wireless-Erlebnis im Wettkampf.Angetrieben vom Nordic 54L15-Chip mit einer Kernfrequenz, die doppelt so hoch ist wie die von 52840-Chips, bietet die V8 zwei 8K-Abfrageraten für eine ultraschnelle Eingabeaktualisierung.

More news about: ATTACK SHARK


Dec 17, 2025, 06:16 ET ATTACK SHARK dévoile la V8 : Une souris de gaming sans fil légère de nouvelle génération conçue pour dominer la concurrence

d'interrogation et l'état de la batterie, offrant ainsi une expérience sans fil fiable et ininterrompue pour les jeux compétitifs.Basée sur la puce Nordic 54L15 avec une fréquence de processeur deux fois supérieure à celle des puces 52840, la V8 offre un double taux d'interrogation 8K (filaire et sans fil) pour

More news about: ATTACK SHARK


Dec 17, 2025, 00:39 ET WYBOT S3, 새로운 기준으로 수영장 로봇 산업 재정의...호주 출시 임박

있다.https://edge.prnewswire.com/c/link/?t=0&l=en&o=4581470-1&h=1224849858&u=https%3A%2F%2Fwww.au.wybotpool.com%2F&a=https%3A%2F%2Fwww.au.wybotpool.com%2F사진

More news about: WYBOTICS INC


Dec 16, 2025, 20:00 ET Antengene Expands XPOVIO® Indications in Malaysia with Approval in Diffuse Large B-cell Lymphoma

preclinical to commercial stages and includes several in-house discovered programs, including ATG-022 (CLDN18.2 ADC), ATG-037 (oral CD73 inhibitor), ATG-101 (PD-L1 × 4-1BB bispecific antibody), ATG-031 (CD24-targeting macrophage activator), and ATG-042 (oral PRMT5-MTA inhibitor).Antengene has also developed

More news about: Antengene Corporation Limited


Dec 16, 2025, 19:06 ET Sushi Announces Strategic Investment and New Leadership to Accelerate Next Phase of Growth

sustainable business fundamentals.Sushi's ecosystem continues to expand through key partnerships, including the rapid growth of Katana, a Layer 2 (L2) network supported by Polygon. Katana has accumulated over $100 million in TVL on Sushi, strengthening Sushi's position as a foundational liquidity and

More news about: SushiSwap


Dec 16, 2025, 19:04 ET Harbour BioMed Enters into Global Strategic Collaboration and License Agreement with Bristol Myers Squibb to Discover and Develop Next-Generation Multi-Specific Antibodies

acquisitions.The proprietary antibody technology platform Harbour Mice® generates fully human monoclonal antibodies in two heavy and two light chains (H2L2) format, as well as heavy chain only (HCAb) format. Building upon the HCAb antibodies, the HCAb-based immune cell engagers (HBICE®) bispecific

More news about: Harbour BioMed


Dec 16, 2025, 17:43 ET Chirey Motor México y Tigres construyen un legado de perseverancia e ingeniería de alto nivel en México

una de las más altas del segmento.Gracias a la coordinación inteligente de su sistema, este SUV logra un consumo combinado WLTC de apenas 1.3 L/100 km, lo que brinda a las familias que recorren largas distancias una experiencia más eficiente, cómoda y amigable con el medio ambiente.Este

More news about: Chirey Motor México


Dec 16, 2025, 17:09 ET Chirey Super Hybrid (CSH) se presenta como una solución integral para viajar en invierno con mayor autonomía, seguridad y eficiencia

adversas. En el mercado mexicano, TIGGO 8 CSH registra un consumo combinado WLTC de 1.3 L/100 km, mientras que TIGGO 7 CSH alcanza una autonomía superior a 1,200 km, con un consumo de 4.9 L/100 km en modo de carga sostenida, manteniendo un equilibrio entre desempeño y eficiencia

More news about: Chirey Motor México


Dec 16, 2025, 17:00 ET Inhibrx Biosciences Provides Progress Updates on the INBRX-106 Program and the Expansion Cohorts of the ozekibart (INBRX-109) Program

quarter of 2026. This trial is recruiting patients who have not received prior systemic therapy for unresectable or metastatic HNSCC and have tumor PD-L1 CPS expression equal to or greater than 20. Patients are randomized one to one to either INBRX-106 in combination with Keytruda or Keytruda. The primary

More news about: Inhibrx Biosciences, Inc.


Dec 16, 2025, 16:15 ET Bank of America Declares Preferred Stock Dividends Payable in January and February 2026

7.25% Non-Cumulative Perpetual Convertible Preferred Stock, Series L

More news about: Bank of America Corporation


Dec 16, 2025, 13:40 ET UT San Antonio announces transformational $30 million gift from the Kate Marmion Charitable Foundation for the Kate Marmion School of Public Health

and granddaughter of former Gov. Dolph Briscoe Jr. and Janey Slaughter Briscoe.Established in 2022 under the joint vision of the late William L. Henrich, MD, former president of UT Health San Antonio, and UT San Antonio President Taylor Eighmy, PhD, the Kate Marmion School of Public

More news about: UT Health San Antonio


Dec 16, 2025, 13:17 ET Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B

positive clinical progress in its ongoing DURIPANC clinical trial combining Ampligen and AstraZeneca's anti-PD-L1 immune checkpoint inhibitor Imfinzi for metastatic pancreatic cancer. The company reported Q3 2025 research and development expenses of approximately

More news about: USA News Group


Dec 16, 2025, 13:00 ET Advita Ortho Wins Innovation Award for Soft Tissue Balancing in Knee Replacement Surgery

Presented at the 19th Annual Meeting of the International Society for Computer Assisted Orthopaedic Surgery, Vol 3, Pages 98-101.Angibaud L et al. Ability to Achieve Mediolateral Gap Balance with Instrumented Navigated Total Knee Arthroplasty – A Review of the First 150 Cases. CAOS 2022.Chinimilli

More news about: Advita Ortho, LLC


Dec 16, 2025, 12:05 ET Thunes ernennt Chloé Mayenobe zur stellvertretenden Geschäftsführerin, um strategisches Wachstum und globale Skalierung voranzutreiben

Bereichsleiterin auf Senior-Ebene und Geschäftsführerin für EMEA bei der Ingenico Group. In diesen Funktionen hat sie erfolgreich Ergebnisverantwortung (P&L) von mehr als 400 Mio. Euro getragen und einen enormen Unternehmenswert geschaffen, darunter ein Beitrag zur 12-fachen Steigerung der Marktkapitalisierung

More news about: Thunes


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.